Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 429, pseudogene (RN7SL429P)

Target
RN7SL429P
Molecular classification
Other (Pseudogene, non-coding RNA, 7SL RNA pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 429, pseudogene (RN7SL429P) is a human pseudogene classified as a non-coding RNA. It is a truncated, non-functional homolog of the 7SL RNA, which itself is a component of the signal recognition particle (SRP) complex essential for protein translocation across the endoplasmic reticulum membrane[1][3][6][9]. The 7SL pseudogenes, such as RN7SL429P, are generated by the reverse transcription of 7SL RNA into genomic DNA, but do not encode functional products and typically lack biological activity[3][4][6]. Unlike authentic 7SL RNA genes, most of these pseudogenes are not expressed or are expressed at very low levels and do not participate directly in cellular processes[1][9]. While there is growing recognition that some pseudogenes may play regulatory roles through RNA-mediated mechanisms—such as competing endogenous RNAs (ceRNAs) that can modulate the availability of microRNAs to parental genes—there is no evidence that RN7SL429P itself carries any such function or is involved in disease processes[2][4][9]. RN7SL429P is not a recognized therapeutic target, receptor, enzyme, or drug-interacting protein.

Other names
RN7SL429PRNA, 7SL, cytoplasmic 429, pseudogene
02

Biological functions

Other (Generally nonfunctional; may occasionally serve regulatory or competing endogenous RNA [ceRNA] roles[2][4])
03

Disease associations

Other (No direct disease associations or roles established; pseudogenes in general may be involved in gene regulation in rare cases[2][4])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 429, pseudogene (RN7SL429P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 429, pseudogene (RN7SL429P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call